Lyra Therapeutics, Inc. - Common Stock, $0.001 par value per share (the "Shares") (LYRA)

Historical Holders from Q2 2020 to Q1 2025

Symbol
LYRA on Nasdaq
CUSIP
55234L105
Type / Class
Equity / Common Stock, $0.001 par value per share (the "Shares")
Shares outstanding
66.2M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
26.9M
Holdings value
$5.54M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
53
Number of buys
26
Number of sells
-25
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value per share (the "Shares") (LYRA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 1.06% $126K 702K Nantahala Capital Management, LLC Sep 30, 2024

Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value per share (the "Shares") (LYRA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 102K $13K +$3.48K $0.13 2
2024 Q4 26.9M $5.54M -$1.49M $0.21 53
2024 Q3 32.5M $8.36M -$118K $0.26 60
2024 Q2 32.7M $9.06M -$111M $0.28 50
2024 Q1 45.6M $283M +$20.6M $6.22 78
2023 Q4 42.4M $222M +$30M $5.24 61
2023 Q3 31.9M $125M -$8.08M $3.91 44
2023 Q2 33.7M $138M +$60.9M $4.11 38
2023 Q1 18.9M $38.1M -$236K $2.01 30
2022 Q4 19.1M $59.9M -$487K $3.14 34
2022 Q3 19.2M $96M -$622K $5.01 32
2022 Q2 19.3M $109M +$80.7M $5.65 31
2022 Q1 5.02M $20.2M -$472K $4.02 24
2021 Q4 5.05M $22M -$3.58M $4.36 30
2021 Q3 6.67M $60.8M -$2.87M $9.14 34
2021 Q2 6.86M $55.1M -$6.26M $8.03 37
2021 Q1 7.56M $87.6M -$11.8M $11.59 49
2020 Q4 8.6M $98M +$10.2M $11.40 43
2020 Q3 7.66M $85.7M +$6.83M $11.18 39
2020 Q2 7.04M $79.8M +$79.8M $11.34 43